ConforMIS Q2 revenue hits $19.2M, net loss at $10.9M: 8 things to know

ConforMIS reported a total revenue increase for the second quarter over the same period last year.

Advertisement

Here are eight things to know about the company’s financial report:

 

1. ConforMIS achieved $19.2 million in total revenue, which includes a $3.5 million settlement related to patent litigation. This is a 72 percent increase over the same period last year.

 

2. Achieved product revenue was $15.8 million, up 41 percent year-over-year. The company reported product revenue from sales of iTotal CR, iUni and iDuo was up $4 million over the same period last year. The product sales of iTotal PS, which was only launched on a limited basis in the United States this past February, was $600,000 in the second quarter.

 

3. The company completed an initial public offering and received around $140 million in net proceeds in July.

 

4. ConforMIS reported a net loss at $10.9 million, or $2.51 per share. This is slightly higher than $10.5 million reported in the same period last year.

 

5. Total operating expenses increased $4.8 million to $19.4 million. This is a 33 percent increase driven primarily by higher sales and marketing, and general and administrative expenses.

 

6. GAAP gross profit increase was $4.5 million, or 110 percent over the same period last year.

 

7. The company expects $72 million to $74 million in total revenue for 2015, which is a 50 percent to 54 percent increase over 2014. This includes $3 million of currency headwind in the company’s revenue results.

 

8. The product revenue is expected to reach $68 million to $70 million, up 42 percent to 46 percent over 2014. The royalty revenue for 2015 is expected to reach $4 million.

 

More articles on orthopedic devices:
5 key notes on Invuity’s new CFO
FDA clears MAKO technology for total knee replacement
K2M, InVivo Therapeutics, Zimmer & more—19 key notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.